ICON Public (ICLR) Stock Insights
ICLR$203.28+20.30 +11.09%
$15.68B
Market Cap
48.18
P/E
19.24
Forward P/E
46
Score
ICON Public (ICLR) Stock Insights
ICLR price $203.28 +20.30 +11.09%
- Ticker
- ICLR
- Price
- $203.28
- Change
- +20.30 +11.09%
- Market cap ?
- $15.68B
- P/E ?
- 48.18
- Forward P/E ?
- 19.24
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 46
- Value
- 60
- Quality
- 44
- Growth
- 35
Stocklytics score rationale: value 60, quality 44, growth 35.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1666487000 | 1758439000 | 2595777000 | 2805839000 | 2797288000 | 5480826000 | 7741386000 | 8120176000 | 8281676000 | 8251340000 |
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also…
Fair value
ICLR fair value $253.05. Price $203.28. Price is 20% below fair value.
Above fair value, and more expensive than usual. A larger premium than on 67% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.35B. Growth 10.47%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 11.12% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 77.15M. Net debt 2.91B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-05-26 | — | 2.85 | — | 2.06B |
| 2027-02-24 | — | 2.87 | — | 2.03B |
| 2026-10-27 | 2.66 | 2.62 | 2.02B | 2.01B |
| 2026-07-29 | 2.56 | 2.55 | 2.06B | 2.00B |
| 2026-06-23 | 2.50 | 2.46 | 2.03B | 2.00B |
| 2026-05-27 | 2.52 | 3.13 | 2.11B | 1.98B |
| 2025-10-22 | 3.31 | 3.28 | 2.04B | 1.98B |
| 2025-07-23 | 3.26 | 3.19 | 2.02B | 1.98B |
| 2025-04-30 | 3.19 | 3.11 | 2.00B | 2.01B |
| 2025-02-19 | 3.43 | 3.41 | 2.04B | 2.04B |
| 2024-10-23 | 3.35 | 3.84 | 2.03B | 2.13B |
| 2024-07-24 | 3.75 | 3.68 | 2.12B | 2.14B |
| 2024-04-24 | 3.47 | 3.41 | 2.09B | 2.09B |
| 2024-02-21 | 3.46 | 3.44 | 2.07B | 2.09B |
| 2023-10-26 | 3.30 | 3.28 | 2.06B | 2.05B |
| 2023-07-27 | 3.11 | 3.08 | 2.02B | 2.02B |
| 2023-04-27 | 2.90 | 2.88 | 1.98B | 1.98B |
| 2023-02-23 | 3.13 | 3.05 | 1.96B | 1.96B |
| 2022-11-02 | 3.00 | 2.94 | 1.94B | 1.94B |
| 2022-07-27 | 2.86 | 2.79 | 1.94B | 1.93B |
| 2022-04-27 | 2.76 | 2.70 | 1.90B | 1.89B |
| 2022-02-22 | 2.63 | 2.62 | 1.89B | 1.90B |
| 2021-11-03 | 2.55 | 2.42 | 1.87B | 1.77B |
| 2021-07-21 | 2.12 | 2.09 | 871.15M | 1.83B |
| 2021-04-28 | 2.06 | 1.97 | 858.20M | 751.01M |
| 2021-02-24 | 1.90 | 1.83 | 760.23M | 751.17M |
| 2020-10-21 | 1.72 | 1.53 | 701.73M | 624.21M |
| 2020-07-22 | 1.20 | 1.10 | 620.23M | 568.54M |
| 2020-04-22 | 1.70 | 1.68 | 715.10M | 706.69M |
| 2020-02-19 | 1.83 | 1.83 | 725.41M | 725.41M |
| 2019-10-23 | 1.74 | 1.74 | 710.44M | 710.44M |
| 2019-07-24 | 1.69 | 1.68 | 695.14M | 691.02M |
| 2019-05-01 | 1.63 | 1.60 | 674.85M | 662.43M |
| 2019-02-20 | 1.62 | 1.60 | 679.02M | 670.64M |
| 2018-10-24 | 1.54 | 1.54 | 655.02M | 655.02M |
| 2018-07-25 | 1.51 | 1.48 | 641.61M | 628.85M |
| 2018-05-02 | 1.42 | 1.42 | 620.12M | 620.10M |
| 2018-02-15 | 1.43 | 1.42 | 455.14M | 451.92M |
| 2017-10-26 | 1.35 | 1.32 | 440.32M | 430.52M |
| 2017-07-27 | 1.31 | 1.30 | 431.02M | 427.71M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-23 | Lyons Emer | Sell | 42 | $180.54 | 7.58K |
| 2026-10-23 | Lyons Emer | Sell | 81 | $181.39 | 14.69K |
| 2026-10-23 | Lyons Emer | Sell | 43 | $182.30 | 7.84K |
| 2026-10-23 | Lyons Emer | Sell | 52 | $183.42 | 9.54K |
| 2026-10-23 | Lyons Emer | Sell | 54 | $184.29 | 9.95K |
| 2026-10-22 | Lyons Emer | Buy | 510 | — | — |
| 2026-10-22 | Lyons Emer | Sell | 510 | — | — |
| 2026-09-17 | McCague Eugene Pacelli | Buy | 3.25K | $125.74 | 409.28K |
| 2026-09-17 | McCague Eugene Pacelli | Sell | 3.25K | $175.00 | 569.62K |
| 2026-09-17 | McCague Eugene Pacelli | Sell | 3.25K | $125.74 | 409.28K |
| 2026-09-17 | Murphy Ronan Martin | Buy | 5.00K | $125.74 | 629.33K |
| 2026-09-17 | Murphy Ronan Martin | Sell | 5.00K | $175.00 | 875.88K |
| 2026-09-17 | Murphy Ronan Martin | Sell | 5.00K | $125.74 | 629.33K |
| 2026-09-16 | CLIMAX JOHN DR | Buy | 5.00K | $125.74 | 629.33K |
| 2026-09-16 | CLIMAX JOHN DR | Sell | 5.00K | $175.00 | 875.88K |
| 2026-09-16 | CLIMAX JOHN DR | Sell | 5.00K | $125.74 | 629.33K |
| 2026-08-11 | Whitaker Anne Clem | Sell | 88 | $162.72 | 14.32K |
| 2026-08-11 | Whitaker Anne Clem | Sell | 96 | $163.77 | 15.72K |
| 2026-08-11 | Whitaker Anne Clem | Sell | 590 | $164.47 | 97.04K |
| 2026-08-11 | Whitaker Anne Clem | Sell | 67 | $165.51 | 11.09K |
| 2026-08-11 | O'Neill Julie | Sell | 95 | $162.72 | 15.46K |
| 2026-08-11 | O'Neill Julie | Sell | 105 | $163.77 | 17.20K |
| 2026-08-11 | O'Neill Julie | Sell | 642 | $164.47 | 105.59K |
| 2026-08-11 | O'Neill Julie | Sell | 73 | $165.51 | 12.08K |
| 2026-08-11 | Murray Ciaran | Sell | 280 | $162.72 | 45.56K |
| 2026-08-11 | Murray Ciaran | Sell | 305 | $163.77 | 49.95K |
| 2026-08-11 | Murray Ciaran | Sell | 1.88K | $164.47 | 309.20K |
| 2026-08-11 | Murray Ciaran | Sell | 212 | $165.51 | 35.09K |
| 2026-08-11 | Murphy Ronan Martin | Sell | 88 | $162.72 | 14.32K |
| 2026-08-11 | Murphy Ronan Martin | Sell | 96 | $163.77 | 15.72K |
| 2026-08-11 | Murphy Ronan Martin | Sell | 590 | $164.47 | 97.04K |
| 2026-08-11 | Murphy Ronan Martin | Sell | 67 | $165.51 | 11.09K |
| 2026-08-11 | McCague Eugene Pacelli | Sell | 88 | $162.72 | 14.32K |
| 2026-08-11 | McCague Eugene Pacelli | Sell | 96 | $163.77 | 15.72K |
| 2026-08-11 | McCague Eugene Pacelli | Sell | 590 | $164.47 | 97.04K |
| 2026-08-11 | McCague Eugene Pacelli | Sell | 67 | $165.51 | 11.09K |
| 2026-08-11 | Grais Linda | Sell | 87 | $162.72 | 14.16K |
| 2026-08-11 | Grais Linda | Sell | 97 | $163.77 | 15.89K |
| 2026-08-11 | Grais Linda | Sell | 590 | $164.47 | 97.04K |
| 2026-08-11 | Grais Linda | Sell | 67 | $165.51 | 11.09K |
| 2026-08-11 | CLIMAX JOHN DR | Sell | 88 | $162.72 | 14.32K |
| 2026-08-11 | CLIMAX JOHN DR | Sell | 95 | $163.77 | 15.56K |
| 2026-08-11 | CLIMAX JOHN DR | Sell | 591 | $164.47 | 97.20K |
| 2026-08-11 | CLIMAX JOHN DR | Sell | 67 | $165.51 | 11.09K |
| 2026-08-11 | Clerkin Nigel Bernard John | Sell | 237 | $162.72 | 38.56K |
| 2026-08-11 | Clerkin Nigel Bernard John | Sell | 259 | $163.77 | 42.42K |
| 2026-08-11 | Clerkin Nigel Bernard John | Sell | 1.59K | $164.47 | 261.67K |
| 2026-08-11 | Clerkin Nigel Bernard John | Sell | 180 | $165.51 | 29.79K |
| 2026-08-10 | Whitaker Anne Clem | Buy | 1.73K | — | — |
| 2026-08-10 | Whitaker Anne Clem | Buy | 1.32K | — | — |
| 2026-08-10 | Whitaker Anne Clem | Sell | 1.73K | — | — |
| 2026-08-10 | O'Neill Julie | Buy | 1.73K | — | — |
| 2026-08-10 | O'Neill Julie | Buy | 1.32K | — | — |
| 2026-08-10 | O'Neill Julie | Sell | 1.73K | — | — |
| 2026-08-10 | Murray Ciaran | Buy | 2.68K | — | — |
| 2026-08-10 | Murray Ciaran | Buy | 2.05K | — | — |
| 2026-08-10 | Murray Ciaran | Sell | 2.68K | — | — |
| 2026-08-10 | Murphy Ronan Martin | Buy | 1.73K | — | — |
| 2026-08-10 | Murphy Ronan Martin | Buy | 1.32K | — | — |
| 2026-08-10 | Murphy Ronan Martin | Sell | 1.73K | — | — |
| 2026-08-10 | McCague Eugene Pacelli | Buy | 1.73K | — | — |
| 2026-08-10 | McCague Eugene Pacelli | Buy | 1.32K | — | — |
| 2026-08-10 | McCague Eugene Pacelli | Sell | 1.73K | — | — |
| 2026-08-10 | Lyons Emer | Buy | 5.89K | — | — |
| 2026-08-10 | Grais Linda | Buy | 1.73K | — | — |
| 2026-08-10 | Grais Linda | Buy | 1.32K | — | — |
| 2026-08-10 | Grais Linda | Sell | 1.73K | — | — |
| 2026-08-10 | CLIMAX JOHN DR | Buy | 1.73K | — | — |
| 2026-08-10 | CLIMAX JOHN DR | Buy | 1.32K | — | — |
| 2026-08-10 | CLIMAX JOHN DR | Sell | 1.73K | — | — |
| 2026-08-10 | Clerkin Nigel Bernard John | Buy | 14.16K | — | — |
| 2026-08-10 | Clerkin Nigel Bernard John | Buy | 3.38K | — | — |
| 2026-08-10 | Clerkin Nigel Bernard John | Sell | 3.38K | — | — |
| 2026-08-10 | Clerkin Nigel Bernard John | Buy | 4.79K | $166.05 | 795.88K |
| 2026-08-10 | Clerkin Nigel Bernard John | Buy | 918 | — | — |
| 2026-08-10 | Clerkin Nigel Bernard John | Sell | 918 | — | — |
| 2026-08-10 | Egan Kevin Francis | Buy | 1.32K | — | — |
| 2026-08-10 | Elliott Jeffrey Thomas | Buy | 1.32K | — | — |
| 2026-08-10 | Balfe Barry Edward | Buy | 32.63K | $166.05 | 5.42M |
| 2026-08-10 | Balfe Barry Edward | Buy | 22.26K | — | — |
| 2026-08-10 | Balfe Barry Edward | Sell | 304 | $163.80 | 49.80K |
| 2026-08-10 | Balfe Barry Edward | Sell | 78 | $165.14 | 12.88K |
| 2026-08-07 | Balfe Barry Edward | Buy | 728 | — | — |
| 2026-08-07 | Balfe Barry Edward | Sell | 728 | — | — |
| 2026-06-01 | Egan Kevin Francis | Other | 0 | — | — |
| 2026-06-01 | Elliott Jeffrey Thomas | Other | 0 | — | — |
| 2026-05-14 | Murphy Ronan Martin | Buy | 5.00K | $125.74 | 629.33K |
| 2026-05-14 | Murphy Ronan Martin | Sell | 5.00K | $125.74 | 629.33K |
| 2026-05-14 | CLIMAX JOHN DR | Buy | 5.00K | $125.74 | 629.33K |
| 2026-05-14 | CLIMAX JOHN DR | Sell | 5.00K | $125.74 | 629.33K |
| 2026-05-14 | McCague Eugene Pacelli | Buy | 3.25K | $125.74 | 409.28K |
| 2026-05-14 | McCague Eugene Pacelli | Sell | 3.25K | $125.74 | 409.28K |
| 2026-03-18 | Balfe Barry Edward | Other | 0 | — | — |
| 2026-03-18 | Balfe Barry Edward | Other | 4.48K | $233.88 | 1.05M |
| 2026-03-18 | Balfe Barry Edward | Other | 3.40K | $231.68 | 788.87K |
| 2026-03-18 | Balfe Barry Edward | Other | 15.33K | $185.18 | 2.84M |
| 2026-03-18 | Balfe Barry Edward | Other | 2.13K | $174.96 | 372.84K |
| 2026-03-18 | Balfe Barry Edward | Other | 4.91K | $325.51 | 1.60M |
| 2026-03-18 | Balfe Barry Edward | Other | 886 | $159.33 | 141.17K |
| 2026-03-18 | Balfe Barry Edward | Other | 1.66K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 450, holders +6 vs prior quarter. Ownership 104.59%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 8.64M | 357.46K | +4.32% | 1.50B |
| WELLINGTON MANAGEMENT GROUP LLP | 5.32M | -592.98K | -10.03% | 924.15M |
| FMR LLC | 5.27M | 1.10M | +26.29% | 915.68M |
| INVESCO LTD. | 5.26M | 1.39M | +35.72% | 914.45M |
| HARRIS ASSOCIATES L P | 4.47M | 116.83K | +2.68% | 776.16M |
| BRAVE WARRIOR ADVISORS, LLC | 3.15M | 156.50K | +5.22% | 547.76M |
| GREENHAVEN ASSOCIATES INC | 3.10M | 1.10M | +54.84% | 538.61M |
| PRINCIPAL FINANCIAL GROUP INC | 2.95M | -360.80K | -10.89% | 512.61M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.11M | -622.65K | -22.83% | 369.45M |
| RUANE, CUNNIFF & GOLDFARB L.P. | 2.05M | 413.48K | +25.30% | 355.77M |
| BOSTON PARTNERS | 1.62M | 785.59K | +94.07% | 281.40M |
| TRINITY STREET ASSET MANAGEMENT LLP | 1.54M | 327.31K | +27.09% | 266.73M |
| D. E. SHAW & CO., INC. | 1.36M | 158.59K | +13.23% | 235.75M |
| DIMENSIONAL FUND ADVISORS LP | 1.27M | 481.40K | +61.03% | 220.65M |
| EARNEST PARTNERS LLC | 1.24M | 356.85K | +40.29% | 215.86M |
| MAPLE ROCK CAPITAL PARTNERS INC. | 1.20M | 864.30K | +257.77% | 208.38M |
| 1832 ASSET MANAGEMENT L.P. | 1.19M | 1.62K | +0.14% | 207.56M |
| BRANDES INVESTMENT PARTNERS, LP | 1.19M | -249.28K | -17.37% | 205.98M |
| CAPITAL WORLD INVESTORS | 1.11M | 1.23K | +0.11% | 192.13M |
| AMERIPRISE FINANCIAL INC | 979.60K | 877.36K | +858.16% | 170.17M |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 961.66K | 42.95K | +4.68% | 167.05M |
| SEI INVESTMENTS CO | 902.18K | 144.70K | +19.10% | 156.72M |
| EQUITY INVESTMENT CORP | 888.88K | -207.52K | -18.93% | 154.41M |
| LYRICAL ASSET MANAGEMENT LP | 881.18K | -57.02K | -6.08% | 153.07M |
| ALLIANCEBERNSTEIN L.P. | 1.38M | 33.60K | +2.50% | 152.51M |
Insights · Dividends · Forecast · Financials · Learn